Healthcare Services Group Stock (NASDAQ: HCSG)

Healthcare Services Group (NASDAQ:HCSG) Stock, Quote.Headers.trade-ideas

Healthcare Services Group

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

AZTR

ENGN

HCSG

LYFT

QDEL

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday.

The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to 15,765.18. The S&amp;P 500 also rose, gaining, 0.49% to 4,977.43.

Dow Edges Higher; QuidelOrtho Shares Plummet

Movers

ABNB

AKAM

ALSN

ANGI

BGLC

BLNK

CART

CCTG

CEVA

CLNN

CNVS

COGT

COIN

DTSS

EEIQ

ELWS

GLDD

GMBL

HOOD

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

IREN

KTOS

Larimar Therapeutics, Inc. - Common Stock

LRMR

MGOL

NUKK

QRTEB

REZI

SNTG

Sony Group Corporation American Depositary Shares

SONY

SUNW

TSEM

UFCS

UPST

VBIV

Shares of  Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday.

The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&amp;P 500 also rose, gaining, 0.11% to 4,958.84.

Crude Oil Moves Lower; Louisiana-Pacific Posts Upbeat Earnings

Healthcare Services Group, Inc. - Common Stock

Healthcare Services Group Inc

<p>Healthcare Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) today announced the appointment of Vikas Singh as EVP &amp; Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy.</p>
<p>Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance &amp; Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began his career with GSK's Consumer Healthcare Division and held roles in Sales Management and as National Brand Manager within the marketing organization.</p>


Management

HCSG Announces Appointment Of Vikas Singh As Chief Financial Officer, Effective September 3, 2024

<p>Benchmark  analyst Bill Sutherland   reiterates Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Buy and maintains $17 price target.</p>


Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Healthcare Services Group, Maintains $17 Price Target

<p>RBC Capital  analyst Sean Dodge   maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Outperform and lowers the price target from $15 to $14.</p>


RBC Capital Maintains Outperform on Healthcare Services Group, Lowers Price Target to $14

<p>Baird  analyst Andrew Wittmann   maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Neutral and raises the price target from $13 to $14.</p>


Baird Maintains Neutral on Healthcare Services Group, Raises Price Target to $14

Guidance

Health Care

General

Healthcare Services Group Expects Q3 And Q4 Revenue Of $425M-$435M And $430M-$440M, Compared To Consensus Of $431.14M And $437.04M, Respectively

Healthcare Services Group Q2 2024 Adj. EPS $0.20, Inline, Sales $426.288M Beat $424.901M Estimate

<p>Healthcare Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) today issued the following statement in response to LaVie Care Centers' announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Georgia. As a result of LaVie's filing, the Company estimates a Q2 non-cash charge of approximately $0.20 per share. The Company expects to continue providing services to LaVie and expects no impact on future revenue or earnings. Additionally, the Company anticipates no disruption in postpetition payments and reiterates its previously shared Q2 and 2024 adjusted cash flow expectations of $5.0 million to $15.0 million and $40.0 million to $55.0 million, respectively.</p>


HCSG Provides Update On Client Restructuring; Estimates A Q2 Non-cash Charge Of ~$0.20 Per Share, Anticipates No Disruption In Postpetition Payments And Reiterates Its Previously Shared Q2 And 2024 Adjusted Cash Flow Expectations Of $5M-$15M And $40M-$55M

Healthcare Services Reiterates 2024 Forecast For Adjusted Cash Flow Range Of $40M-$55M; Expects Q2 Revenue In The Range Of $420M-$430M Vs. $430.417M Consensus

<p>Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.19 by 15.79 percent. This is a 10 percent increase over earnings of $0.20 per share from the same period last year.  The company reported quarterly sales of $423.433 which missed the analyst consensus estimate of $424.949 million by 100.00 percent.  This is a 100.00 percent decrease over sales of $417.230 million the same period last year.</p>


Earnings Beats

Earnings Misses

Healthcare Services Group Q1 2024 Adj EPS $0.22 Beats $0.19 Estimate, Sales $423.433 Miss $424.949M Estimate

<p>Benchmark  analyst Bill Sutherland   maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Buy and raises the price target from $16 to $17.</p>


Benchmark Maintains Buy on Healthcare Services Group, Raises Price Target to $17

<p>Across the recent three months, 5 analysts have shared their insights on Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Healthcare Services Group, presenting an average target of $13.6, a high estimate of $16.00, and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 16.54% increase from the previous average price target of $11.67.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1708020033_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The perception of Healthcare Services Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Bill Sutherland</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$11.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Healthcare Services Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Healthcare Services Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Healthcare Services Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Healthcare Services Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HCSG/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Healthcare Services Group analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Healthcare Services Group Better</h2>
<p>Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.</p>
<h3>Key Indicators: Healthcare Services Group's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Healthcare Services Group's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2023, the company experienced a revenue decline of approximately <strong>-0.75%</strong>. This indicates a decrease in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-1.34%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>-1.23%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Healthcare Services Group's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.73%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Healthcare Services Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.13</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Evaluating Healthcare Services Group: Insights From 5 Financial Analysts

<p>RBC Capital  analyst Sean Dodge   maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Outperform and raises the price target from $14 to $15.</p>


RBC Capital Maintains Outperform on Healthcare Services Group, Raises Price Target to $15

<p>U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday.</p>
<p>The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to 15,765.18. The S&amp;P 500 also rose, gaining, 0.49% to 4,977.43.</p>
<p>Check This Out: <a href="https://www.benzinga.com/news/24/02/37091624/snap-american-express-and-2-other-stocks-insiders-are-selling"><em> Snap, American Express And 2 Other Stocks Insiders Are Selling</em></a></p>
<p>&nbsp;</p>
<h3><strong>Leading and Lagging Sectors</strong></h3>
<p>&nbsp;</p>
<p>Industrials shares rose by 1.1% on Wednesday.</p>
<p>In trading on Wednesday, consumer staples shares fell by 0.6%.</p>
<p>&nbsp;</p>
<h3><strong>Top Headline</strong></h3>
<p>&nbsp;</p>
<p>Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise.</p>
<p>&nbsp;</p>
<h3><strong>Equities Trading UP</strong></h3>
<p>&nbsp;</p>
<p><strong>enGene Holdings Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) shares shot up 83% to $13.95. The company&rsquo;s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day&rsquo;s closing price.</p>
<p>Shares of <strong> Lyft, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) got a boost, surging 33% to $16.10 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.</p>
<p><strong>Healthcare Services Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) shares were also up, gaining 26% to $11.91 following upbeat earnings.</p>
<p>&nbsp;</p>
<h3><strong>Equities Trading DOWN</strong></h3>
<p>&nbsp;</p>
<p><strong>Azitra, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) shares dropped 71% to $0.2540. Azitra priced its $5 million public offering of 16.667 million common shares at $0.30 per share.</p>
<p>Shares of <strong> QuidelOrtho Corporation </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) were down 29% to $47.17 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 adjusted EPS below estimates.</p>
<p><strong>Ohmyhome Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) was down, falling 38% to $1.40 after the company priced its upsized $4.8 million public offering of 3,555,555 ordinary shares at $1.35 per share.</p>
<p>Also Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37120560/retractable-technologies-and-2-other-stocks-under-5-insiders-are-buying"><em> Retractable Technologies And 2 Other Stocks Under $5 Insiders Are Buying</em></a></p>
<p>&nbsp;</p>
<h3><strong>Commodities</strong></h3>
<p>&nbsp;</p>
<p>In commodity news, oil traded down 1.2% to $76.95 while gold traded down 0.2% at $2,004.20.</p>
<p>Silver traded up 1.2% to $22.425 on Wednesday while copper fell 0.3% to $3.6985.</p>
<p>&nbsp;</p>
<h3><strong>Euro zone</strong></h3>
<p>&nbsp;</p>
<p>European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.50%, London&rsquo;s FTSE 100 rose 0.75% while Spain&rsquo;s IBEX 35 Index fell 0.09% The German DAX rose 0.38% French CAC 40 rose 0.68% while Italy&rsquo;s FTSE MIB Index rose 0.63%.</p>
<p>The Eurozone economy stagnated in the final quarter of 2023, compared to a 0.1% decline in the prior three-month period. Industrial production in the Eurozone increased by 2.6% month-over-month in December.</p>
<p>The UK&rsquo;s inflation rate came in unchanged at 4.0% in January, compared to market estimates of 4.2%. Factory gate prices of goods produced by UK manufacturers fell 0.6% year-over-year in January following a 0.1% increase in December.</p>
<p>&nbsp;</p>
<h3><strong>Asia Pacific Markets</strong></h3>
<p>&nbsp;</p>
<p>Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.69%, Hong Kong&rsquo;s Hang Seng Index gaining 0.84% and India&rsquo;s S&amp;P BSE Sensex gaining around 0.5%.</p>
<p>India&rsquo;s wholesale prices increased by 0.27% year-over-year in January, compared to 0.73% in December.</p>
<p>&nbsp;</p>
<h3><strong>Economics</strong></h3>
<p>&nbsp;</p>
<p>U.S. mortgage applications declined by 2.3% in the week ending Feb. 9, compared to a 3.7% increase in the prior week.</p>
<p>Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise.</p>
<p>Now Read This: <a href="https://www.benzinga.com/news/24/02/37120605/wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields"><em> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Health Care Stocks Delivering High-Dividend Yields</em></a></p>


<p>Shares of <strong> Sony Group Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sony#NYSE">SONY</a>) fell during Wednesday&rsquo;s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.</p>
<p>Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (&yen;3.75 trillion), beating the consensus of $24.62 billion. Adjusted EPS of $1.99 beat the consensus of $1.65.</p>
<p>Sony revised its FY23 sales outlook to $86.62 billion (&yen;12.4 trillion), down from a prior forecast of &yen;12.3 trillion versus the consensus of $87.32 billion.</p>
<p>Sony Group shares fell 6.3% to $89.86 on Wednesday.</p>
<p>Here are some other stocks moving in today&#39;s mid-day session.</p>
<h3><strong>Gainers</strong></h3>
<ul>
<li><strong>Datasea Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) shares jumped 1,173% to $18.59. On Tuesday, Datasea posted a narrower second-quarter loss.</li>
<li><strong>Earlyworks Co., Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) surged 416% to $2.35 on two passive stakes.</li>
<li><strong>enGene Holdings Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) jumped 95.5% to $14.90. The company&rsquo;s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day&rsquo;s closing price.</li>
<li><strong>Cineverse Corp.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnvs#NASDAQ">CNVS</a>) surged 92.9% to $2.9899. Cineverse announced forthcoming launch of AI-powered movie search platform cineSearch.</li>
<li><strong>Cheche Group Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccg#NASDAQ">CCG</a>) gained 74.3% to $5.49.</li>
<li><strong>MGO Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgol#NASDAQ">MGOL</a>) rose 66% to $0.6647.</li>
<li><strong>Cogent Biosciences, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cogt#NASDAQ">COGT</a>) surged 62.7% to $8.89.</li>
<li><strong>Inspira Technologies Oxy B.H.N. Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iinn#NASDAQ">IINN</a>) gained 35% to $1.29 after the company announced it received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART500 device.</li>
<li><strong>Lyft, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares gained 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.</li>
<li><strong>Healthcare Services Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) gained 25.7% to $11.90 following upbeat earnings.</li>
<li><strong>Blink Charging Co.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnk#NASDAQ">BLNK</a>) gained 24.2% to $3.3288. Blink Charging announced preliminary fourth-quarter revenue excess of $42 million.</li>
<li><strong>Larimar Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrmr#NASDAQ">LRMR</a>) rose 23.9% to $10.83. Larimar Therapeutics has priced the public offering of 17.16 million shares at $8.74 per share for gross proceeds of approximately $150 million.</li>
<li><strong>Clene Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clnn#NASDAQ">CLNN</a>) gained 22.9% to $0.52.</li>
<li><strong>Angi Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angi#NASDAQ">ANGI</a>) gained 22.2% to $2.97 following upbeat earnings.</li>
<li><strong>Iris Energy Limited</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) shares rose 20.5% to $8.35.</li>
<li><strong>CEVA, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceva#NASDAQ">CEVA</a>) gained 18.5% to $23.92 following upbeat earnings.</li>
<li><strong>Great Lakes Dredge &amp; Dock Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gldd#NASDAQ">GLDD</a>) gained 17.1% to $9.47 following quarterly results.</li>
<li><strong>Resideo Technologies, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rezi#NYSE">REZI</a>) rose 16.7% to $19.94 after the company reported better-than-expected quarterly financial results.</li>
<li><strong>Kratos Defense &amp; Security Solutions, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) jumped 15.7% to $20.59 following better-than-expected quarterly results.</li>
<li><strong>Robinhood Markets, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) shares gained 14.7% to $13.58 after the company reported better-than-expected fourth-quarter financial results.</li>
<li><strong>United Fire Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufcs#NASDAQ">UFCS</a>) rose 13.5% to $24.32 following upbeat results.</li>
<li><strong>Allison Transmission Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alsn#NASDAQ">ALSN</a>) gained 13% to $69.53 after the company reported better-than-expected quarterly financial results.</li>
<li><strong>MRC Global Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrc#NYSE">MRC</a>) rose 12.1% to $11.64 following upbeat earnings.</li>
<li><strong>Coinbase Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 11.5% to $156.50 amid strength in Bitcoin.</li>
<li><strong>CCSC Technology International Holdings Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) shares rose 10.2% to $3.56 after dipping around 10% on Tuesday.</li>
<li><strong>Tower Semiconductor Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsem#NASDAQ">TSEM</a>) gained 8.5% to $31.07 following strong results.</li>
<li><strong>Sentage Holdings Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares jumped 8.4% to $2.46.</li>
<li><strong>Charles River Laboratories International, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crl#NYSE">CRL</a>) gained 7.2% to $236.00 after the company reported better-than-expected fourth-quarter results and issued guidance above estimates.</li>
<li><strong>VBI Vaccines Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) shares surged 5.2% to $0.6941. Brii Biosciences agreed to acquire VBI&#39;s IP rights in BRII-179 (VBI-2601) and plans to initiate technology transfer to expand clinical and commercial supplies.</li>
</ul>
<h3><strong>Losers</strong></h3>
<ul>
<li><strong>Azitra, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) shares fell 69.5% to $0.2653. Azitra priced its $5 million public offering of 16.667 million common shares at $0.30 per share.</li>
<li><strong>Ohmyhome Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) fell 40.7% to $1.3397 after the company priced its upsized $4.8 million public offering of 3,555,555 ordinary shares at $1.35 per share.</li>
<li><strong>QuidelOrtho Corporation </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) fell 34.9% to $43.49 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 adjusted EPS below estimates.</li>
<li><strong>BioNexus Gene Lab Corp. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) shares fell 34.4% to $1.03 after jumping 282% on Tuesday.</li>
<li><strong>Sunworks, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) fell 34.3% to $0.0662.</li>
<li><strong>Enviva Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) fell 33.2% to $0.2977. Enviva is preparing to file for bankruptcy within days, the Wall Street Journal reported.</li>
<li><strong>EpicQuest Education Group International Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eeiq#NASDAQ">EEIQ</a>) fell 27.5% to $1.16.</li>
<li><strong>Nukkleus Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nukk#NASDAQ">NUKK</a>) shares declined 21.6% to $1.5338 after surging over 55% on Tuesday. Goldman Sachs reported a 7.2% passive stake in Nukkleus as of Dec. 29, 2023.</li>
<li><strong>Upstart Holdings, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) fell 20.5% to $26.19 after the company issued first-quarter revenue guidance below estimates.</li>
<li><strong>Esports Entertainment Group, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) shares fell 20% to $1.48. Esports Entertainment Group announced voluntary delisting from the Nasdaq and transfer to the OTCQB Venture Market.</li>
<li><strong>Qurate Retail, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) declined 18.4% to $4.69.</li>
<li><strong>CAE Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cae#NYSE">CAE</a>) fell 12.2% to $18.36 after the company reported worse-than-expected quarterly financial results.</li>
<li><strong>The Chemours Company</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) dipped 10.5% to $27.29.</li>
<li><strong>Vroom, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrm#NASDAQ">VRM</a>) fell 10.5% to $13.71.</li>
<li><strong>Maplebear Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cart#NASDAQ">CART</a>) fell 7.8% to $25.67 following quarterly results.</li>
<li><strong>MGM Resorts International</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mgm#NYSE">MGM</a>) shares declined 7.4% to $42.29 after the company reported fourth-quarter financial results.</li>
<li><strong>Akamai Technologies, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akam#NASDAQ">AKAM</a>) fell 7.3% to $115.89 after the company reported mixed quarterly financial results.</li>
<li><strong>The Kraft Heinz Company</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/khc#NASDAQ">KHC</a>) declined 5.5% to $34.13 after the company reported mixed quarterly financial results.</li>
<li><strong>Airbnb, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abnb#NASDAQ">ABNB</a>) shares declined 5% to $143.25 after the company reported fourth-quarter financial results.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37126344/bitcoin-surpasses-51-000-stacks-emerges-as-top-gainer"><em> Bitcoin Surpasses $51,000; Stacks Emerges As Top Gainer</em></a></p>


Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li><strong>Clean Energy Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) stock moved upwards by 309.3% to $2.19 during Wednesday's regular session. The company's market cap stands at $85.7 million. </li>
<li><strong>Earlyworks Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) shares rose 227.2% to $1.49. The company's market cap stands at $22.3 million. </li>
<li><strong>Erayak Power Solution Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) shares increased by 121.08% to $1.26. The company's market cap stands at $15.1 million. </li>
<li><strong>Lyft</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) shares increased by 32.88% to $16.12. The company's market cap stands at $6.3 billion. The company's, Q4 earnings came out yesterday. </li>
<li><strong>Blink Charging</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) shares moved upwards by 30.41% to $3.5. The market value of their outstanding shares is at $235.5 million. </li>
<li><strong>Healthcare Services Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) stock increased by 25.42% to $11.87. The company's market cap stands at $876.2 million. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Sunworks</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNW#NASDAQ">SUNW</a>) stock fell 35.4% to $0.07 during Wednesday's regular session. The market value of their outstanding shares is at $3.6 million. </li>
<li><strong>BioNexus Gene Lab</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock declined by 29.3% to $1.11. The company's market cap stands at $19.7 million. </li>
<li><strong>Pixie Dust Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXDT#NASDAQ">PXDT</a>) shares decreased by 20.53% to $3.02. The company's market cap stands at $44.4 million. </li>
<li><strong>Ault Alliance</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) shares declined by 12.17% to $0.46. The company's market cap stands at $1.2 million. </li>
<li><strong>Intelligent Living</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 11.35% to $0.86. The company's market cap stands at $15.5 million. </li>
<li><strong>Sunrise New Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) stock fell 10.99% to $0.88. The company's market cap stands at $23.0 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AULT

CETY

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

ILAG

PXDT

RAYA

12 Industrials Stocks Moving In Wednesday's Intraday Session

<p>U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday.</p>
<p>The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&amp;P 500 also rose, gaining, 0.11% to 4,958.84.</p>
<p>Check This Out: <a href="https://www.benzinga.com/news/24/02/37091624/snap-american-express-and-2-other-stocks-insiders-are-selling"><em> Snap, American Express And 2 Other Stocks Insiders Are Selling</em></a></p>
<p>&nbsp;</p>
<h3><strong>Leading and Lagging Sectors</strong></h3>
<p>&nbsp;</p>
<p>Industrials shares rose by 1% on Wednesday.</p>
<p>In trading on Wednesday, energy shares fell by 0.2%.</p>
<p>&nbsp;</p>
<h3><strong>Top Headline</strong></h3>
<p>&nbsp;</p>
<p><strong>Louisiana-Pacific Corp </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lpx#NYSE">LPX</a>) reported better-than-expected results for its fourth quarter.</p>
<p>Louisiana-Pacific reported a fourth-quarter fiscal 2023 net sales decline of 6.7% year-over-year to $658 million, beating the consensus of $619.97 million. Adjusted EPS was 71 cents, up from 61 cents YoY, beating the consensus of 55 cents</p>
<p>&nbsp;</p>
<h3><strong>Equities Trading UP</strong></h3>
<p>&nbsp;</p>
<p><strong>enGene Holdings Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) shares shot up 75% to $13.34. The company&rsquo;s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day&rsquo;s closing price.</p>
<p>Shares of <strong> Lyft, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) got a boost, surging 34% to $16.22 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.</p>
<p><strong>Healthcare Services Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) shares were also up, gaining 27% to $12.01 following upbeat earnings.</p>
<p>&nbsp;</p>
<h3><strong>Equities Trading DOWN</strong></h3>
<p>&nbsp;</p>
<p><strong>Azitra, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) shares dropped 70% to $0.2626. Azitra priced its $5 million public offering of 16.667 million common shares at $0.30 per share.</p>
<p>Shares of <strong> QuidelOrtho Corporation </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) were down 33% to $44.92 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 adjusted EPS below estimates.</p>
<p><strong>Ohmyhome Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) was down, falling 39% to $1.38 after the company priced its upsized $4.8 million public offering of 3,555,555 ordinary shares at $1.35 per share.</p>
<p>Also Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37120560/retractable-technologies-and-2-other-stocks-under-5-insiders-are-buying"><em> Retractable Technologies And 2 Other Stocks Under $5 Insiders Are Buying</em></a></p>
<p>&nbsp;</p>
<h3><strong>Commodities</strong></h3>
<p>&nbsp;</p>
<p>In commodity news, oil traded down 0.6% to $77.38 while gold traded down 0.5% at $1,998.20.</p>
<p>Silver traded up 0.2% to $22.19 on Wednesday while copper fell 0.2% to $3.7040.</p>
<p>&nbsp;</p>
<h3><strong>Euro zone</strong></h3>
<p>&nbsp;</p>
<p>European shares were higher today. The eurozone&rsquo;s STOXX 600 gained 0.52%, London&rsquo;s FTSE 100 rose 0.69% while Spain&rsquo;s IBEX 35 Index rose 0.01% The German DAX rose 0.41% French CAC 40 rose 0.70% while Italy&rsquo;s FTSE MIB Index rose 0.64%.</p>
<p>The Eurozone economy stagnated in the final quarter of 2023, compared to a 0.1% decline in the prior three-month period. Industrial production in the Eurozone increased by 2.6% month-over-month in December.</p>
<p>The UK&rsquo;s inflation rate came in unchanged at 4.0% in January, compared to market estimates of 4.2%. Factory gate prices of goods produced by UK manufacturers fell 0.6% year-over-year in January following a 0.1% increase in December.</p>
<p>&nbsp;</p>
<h3><strong>Asia Pacific Markets</strong></h3>
<p>&nbsp;</p>
<p>Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.69%, Hong Kong&rsquo;s Hang Seng Index gaining 0.84% and India&rsquo;s S&amp;P BSE Sensex gaining around 0.5%.</p>
<p>India&rsquo;s wholesale prices increased by 0.27% year-over-year in January, compared to 0.73% in December.</p>
<p>&nbsp;</p>
<h3><strong>Economics</strong></h3>
<p>&nbsp;</p>
<p>U.S. mortgage applications declined by 2.3% in the week ending Feb. 9, compared to a 3.7% increase in the prior week.</p>
<p>Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise.</p>
<p>Now Read This: <a href="https://www.benzinga.com/news/24/02/37120605/wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields"><em> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Health Care Stocks Delivering High-Dividend Yields</em></a></p>
<p>&nbsp;</p>


WIIM

Healthcare Services Group shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.

<p>U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.</p>
<p>Shares of <strong> Charles River Laboratories International, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crl#NYSE">CRL</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter results and issued <a href="https://www.benzinga.com/quote/CRL/earnings">guidance above estimates</a>.</p>
<p>Charles River posted adjusted earnings of $2.46 per share, beating market estimates of $2.40 per share. The company&rsquo;s quarterly sales came in at $1.01 billion versus expectations of $991.25 million.</p>
<p>Charles River Laboratories International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crl#NYSE">CRL</a>) rose 7.2% to $236.00 on Wednesday.</p>
<p>Here are some other big stocks recording gains in today&rsquo;s session.</p>
<ul>
<li><strong>Lyft, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares rose 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.</li>
<li><strong>Healthcare Services Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) rose 25.7% to $11.90 following upbeat earnings.</li>
<li><strong>Larimar Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrmr#NASDAQ">LRMR</a>) surged 23.9% to $10.83. Larimar Therapeutics has priced the public offering of 17.16 million shares at $8.74 per share for gross proceeds of approximately $150 million.</li>
<li><strong>Angi Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angi#NASDAQ">ANGI</a>) climbed 22.2% to $2.97 following upbeat earnings.</li>
<li><strong>CEVA, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceva#NASDAQ">CEVA</a>) climbed 18.5% to $23.92 following upbeat earnings.</li>
<li><strong>Great Lakes Dredge &amp; Dock Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gldd#NASDAQ">GLDD</a>) rose 17.1% to $9.47 following quarterly results.</li>
<li><strong>Resideo Technologies, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rezi#NYSE">REZI</a>) jumped 16.7% to $19.94 after the company reported better-than-expected quarterly financial results.</li>
<li><strong>Kratos Defense &amp; Security Solutions, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) rose 15.7% to $20.59 following better-than-expected quarterly results.</li>
<li><strong>Robinhood Markets, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) shares climbed 14.7% to $13.58 after the company reported better-than-expected fourth-quarter financial results.</li>
<li><strong>CleanSpark, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) rose 13.8% to $18.08 amid strength in Bitcoin.</li>
<li><strong>United Fire Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufcs#NASDAQ">UFCS</a>) gained 13.5% to $24.32 following upbeat results.</li>
<li><strong>Marathon Digital Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) jumped 13.3% to $29.13 amid strength in Bitcoin.</li>
<li><strong>Allison Transmission Holdings, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alsn#NASDAQ">ALSN</a>) climbed 13% to $69.53 after the company reported better-than-expected quarterly financial results.</li>
<li><strong>MRC Global Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrc#NYSE">MRC</a>) gained 12.1% to $11.64 following upbeat earnings.</li>
<li><strong>Coinbase Global, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) rose 11.5% to $156.50 amid strength in Bitcoin.</li>
<li><strong>Super Micro Computer, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) gained 11.4% to $881.36.</li>
<li><strong>Uber Technologies, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) gained 11.2% to $76.72 after the company announced an inaugural $7 billion share repurchase authorization.</li>
<li><strong>Riot Platforms, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 10% to $16.98 amid strength in Bitcoin.</li>
<li><strong>IQVIA Holdings Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iqv#NYSE">IQV</a>) gained 9.7% to $236.20 following upbeat results.</li>
<li><strong>Zillow Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/z#NASDAQ">Z</a>) gained 9.6% to $59.06 after the company reported better-than-expected fourth-quarter financial results.</li>
<li><strong>WESCO International, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wcc#NYSE">WCC</a>) gained 9.6% to $145.32.</li>
<li><strong>Tower Semiconductor Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsem#NASDAQ">TSEM</a>) climbed 8.5% to $31.07 following strong results.</li>
<li><strong>Mercury General Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcy#NYSE">MCY</a>) gained 6.6% to $43.02 following strong results.</li>
<li><strong>DaVita Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>) gained 6.4% to $120.91 following upbeat results.</li>
<li><strong>IAC Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iac#NASDAQ">IAC</a>) rose 4.9% to $53.70 following upbeat earnings.</li>
</ul>
<p>&nbsp;</p>
<p>Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37126344/bitcoin-surpasses-51-000-stacks-emerges-as-top-gainer"><em> Bitcoin Surpasses $51,000; Stacks Emerges As Top Gainer</em></a></p>


CLSK

MARA

RIOT

SMCI

UBER

Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday

Healthcare Services Group Q4 Sales $423.84M Miss $424.24M Estimate

Healthcare Services Group Q4 Adj EPS $0.20 Beats $0.16 Estimate

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Despite the market currently undergoing one of the strongest rallies this year, you should still look out for stocks to sell. The market might be cooperating right now, but that&rsquo;s not helping certain businesses. The headwinds are too strong for many of them to take off. Plus, if we see the market start going the opposite way, these businesses would be the first to go under.</p>



<p>Moreover, it&rsquo;s always a good idea to exit bad positions and shift that money to better companies. It&rsquo;s not worth making a contrarian bet on certain stocks that will likely dilute you into oblivion or give you little upside even if they succeed. You&rsquo;re much better off putting your cash into quality companies that aren&rsquo;t missing out on the rally.</p>



<p>With that in mind, here are seven stocks to sell:</p>



<h2>SolarEdge (SEDG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/solaredge-sedg-1600-300x169.jpg" alt="the solar edge logo on an iPhone. SEDG stock"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>SolarEdge</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sedg-stock-quote/"><strong>SEDG</strong></a>) provides solar power optimization and monitoring solutions. The solar sector has faced intensifying headwinds in recent years that show no signs of abating. In Q1, SolarEdge&rsquo;s revenue plummeted 78% year-over-year to just $204 million, as solar sales cratered to $190 million. The company shipped a meager 1.1 million power optimizers and 69,000 inverters &mdash; a troubling sign of eroding demand.</p>



<p>While management touts growth in the commercial segment and battery adoption, I believe these green shoots will be smothered by the macro challenges plaguing solar. It also has a ghastly -77% net margin.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/06/chart-53.png"><img width="1226" height="796" src="https://investorplace.com/wp-content/uploads/2024/06/chart-53.png" alt="Stocks to sell: SolarEdge margins"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>The painful Q1 miss on the bottom line indicates profitability remains a distant dream. As interest rates stay elevated and competing solar suppliers flood the market, I expect SolarEdge&rsquo;s woes to compound in the coming years. By 2025, this once-promising solar player may be forced into diluting shares for cash.</p>



<h2>Healthcare Services Group (HCSG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/healthcare1600a-300x169.jpg" alt="two doctors look over a piece of paper while standing in a hallway"><div>Source: Shutterstock</div></div><p><strong>Healthcare Services Group</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/hcsg-stock-quote/"><strong>HCSG</strong></a>) provides housekeeping, laundry, dining, and nutrition services to the healthcare industry. The company has been struggling since 2017, and I believe its challenges are only intensifying with the new nursing home staffing rule. HCSG has faced a <a href="https://seekingalpha.com/symbol/HCSG/earnings/revisions?period=quarterly" target="_blank">string of negative revenue revisions</a> lately, which is concerning. While management is touting Q1 results as &ldquo;strong,&rdquo; I&rsquo;m not convinced. The <a href="https://simplywall.st/stocks/us/commercial-services/nasdaq-hcsg/healthcare-services-group/news/healthcare-services-group-first-quarter-2024-earnings-eps-be" target="_blank">1.5% revenue growth</a> was actually a miss, and cash collections were disrupted by the Change Healthcare cyberattack. The top line has been very boring here.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/06/chart-54.png"><img width="1226" height="741" src="https://investorplace.com/wp-content/uploads/2024/06/chart-54.png" alt="HCSG revenue"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>Sure, HCSG is profitable for now, and analysts <a target="_blank" href="https://seekingalpha.com/symbol/HCSG/earnings/estimates">predict low double-digit revenue growth</a>. But without a dividend to entice shareholders, I expect the stock to drift lower. There are simply better opportunities out there, in my view, to get more attractive financials and valuations along with a solid dividend yield.</p>



<p>Industry headwinds like inflation, higher borrowing costs, and burdensome regulations aren&rsquo;t going away anytime soon. I&rsquo;d steer clear of HCSG shares at these levels and wait for a better entry point when the outlook improves.</p>



<h2>Methode Electronics (MEI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/mechanic-auto-stocks-300x169.jpg" alt="Mechanic Working Under Vehicle in a Car Service"><div>Source: Gorodenkoff / Shutterstock.com</div></div><p><strong>Methode Electronics</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/mei-stock-quote/"><strong>MEI</strong></a>) manufactures custom-engineered products for automotive, industrial, and other end markets. The company&rsquo;s heavy reliance on the struggling automotive sector is a major red flag for me. MEI&rsquo;s Q3 sales <a href="https://www.investing.com/news/stock-market-news/earnings-call-methode-electronics-faces-decline-amid-ev-market-weakness-93CH-3329864" target="_blank">declined $21 million YOY to $260 million</a>, missing estimates by a worrying $28.5 million. The sales drop was entirely in the auto segment across all regions due to program roll-offs, EV demand weakness, and operational inefficiencies. Management even admitted that the EV outlook is softening in the near term. Its cash holdings are also going lower while debt is going up.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/06/chart-55.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/06/chart-55.png" alt="Cash debt ratio"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>I expect these auto headwinds to linger and weigh heavily on Methode&rsquo;s financials. Analysts <a target="_blank" href="https://seekingalpha.com/symbol/MEI/earnings/estimates">project revenue will fall 6.4%</a> this year and decline again next year. The company is also suffering from higher new program launch costs that are hurting margins. While MEI pays a dividend, I have little confidence in its sustainability, given the thin margins and quarterly net loss. With auto weakness showing no signs of abating, I believe investors should steer clear of Methode stock. The risks far outweigh any potential rewards here.</p>



<h2>PetMed Express (PETS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/pets-stock-300x169.jpg" alt="pets stock: petmeds express company logo on a screen, viewed through a magnifying glass"><div>Source: II.studio / Shutterstock.com</div></div><p><strong>PetMed Express</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/pets-stock-quote/"><strong>PETS</strong></a>) sells pet medication, food, and other health products online. While the overall pet market has been thriving, with pet spending in the U.S. <a target="_blank" href="https://globalpetindustry.com/article/us-pet-industry-sales-saw-a-7-4-increase-in-2023#:~:text=Total%20US%20pet%20industry%20sales,billion%20(%E2%82%AC59.4B).">rising 7% to $147 billion in 2023</a>, according to the American Pet Products Association, PetMed has utterly failed to capitalize on these favorable industry tailwinds.</p>



<p>The company&rsquo;s Q4 FY2024 results were dismal, with <a href="https://www.morningstar.com/news/globe-newswire/9152242/petmeds-announces-its-fourth-quarter-and-fiscal-year-end-financial-results" target="_blank">EPS of -25 cents</a> missing estimates by 25 cents. Sure, revenue grew 6.6% YOY to $66.5 million, but that anemic growth is nothing to celebrate given the booming demand for pet products, especially among younger consumers who are prioritizing pet ownership over having kids.</p>



<p>I see nothing but pain ahead for this stock. The company&rsquo;s margins are showing no signs of improving. I don&rsquo;t see any promising trends in this report that could turn things around anytime soon.</p>



<h2>Rivian (RIVN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/10/rivn1600-7-300x169.png" alt="Rivian (RIVN) All Electric R1T Pickup Truck in a forest green color"><div>Source: Roschetzky Photography / Shutterstock.com</div></div><p><strong>Rivian Automotive</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/rivn-stock-quote/"><strong>RIVN</strong></a>) makes electric vehicles. The company&rsquo;s first-quarter results may have exceeded its outlook, but I remain skeptical about Rivian&rsquo;s long-term prospects. With a <a target="_blank" href="https://www.reuters.com/business/autos-transportation/rivian-posts-quarterly-revenue-beat-cuts-2024-capital-spending-forecast-2024-05-07/#:~:text=Rivian%27s%20net%20loss%20widened%20to,Street%20according%20to%20LSEG%20data.">net loss of $1.24 per share</a>, Rivian continues to hemorrhage cash at an alarming rate. The EV sector as a whole is struggling, especially in the U.S., with most startups perpetually burning through capital while generating lackluster sales.</p>



<p>Despite Rivian capturing a 5.1% EV market share in Q1 and hosting 90% more demo drives, I doubt these initiatives will translate into sustainable profitability. The unveiling of their new mid-sized R2 platform starting at $45,000 seems like a desperate attempt to boost demand in an increasingly crowded market. I don&rsquo;t think the company will be able to sell those at positive margins.</p>



<p>I believe the company will have no choice but to further dilute shareholders with additional cash raises in the coming years. Plus, if we see a second Trump administration, we <a href="https://www.bloomberg.com/news/articles/2024-02-07/biden-s-ev-tax-credits-are-a-ripe-target-for-gutting-if-trump-wins" target="_blank">could also see EV tax credits and subsidies being rolled back</a>. I&rsquo;d steer clear of this stock.</p>



<h2>ChargePoint (CHPT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/chpt1600-300x169.png" alt="Selective focus. Detail of ChargePoint commercial EV electric vehicle charging station on uncovered parking lot. CHPT stock"><div>Source: Michael Vi / Shutterstock.com</div></div><p><strong>ChargePoint</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/chpt-stock-quote/"><strong>CHPT</strong></a>) provides electric vehicle charging solutions. I&rsquo;m growing increasingly concerned about the company&rsquo;s prospects and believe it&rsquo;s one of the stocks to sell. The entire EV sector is facing significant headwinds, and charging companies like ChargePoint are feeling the brunt of it. With fewer EVs on the road than anticipated and intensifying competition, ChargePoint is rapidly losing market share.</p>



<p>Moreover, the company&rsquo;s financials paint a bleak picture. In Q1, ChargePoint reported a staggering <a href="https://finance.yahoo.com/news/chargepoint-reports-first-quarter-fiscal-201000748.html" target="_blank">non-GAAP pre-tax net loss of $45.2 million</a>, and its cash position has dwindled to just $262 million. At this burn rate, I seriously question the sustainability of its business model. Losses are only getting worse.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/06/chart-56.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/06/chart-56.png" alt="ChargePoint revenue and losses"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>Management&rsquo;s talk of achieving adjusted EBITDA positivity by Q4 seems like a pipe dream, given the mounting challenges. Construction delays are already pushing out revenue, and inventory levels are ballooning. Thus, I think it is one of the top stocks to sell right now.</p>



<h2>Virgin Galactic (SPCE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/03/spce1600-300x169.jpg" alt="Virgin Galactic (SPCE) billboard on the New York Stock Exchange, across from the Fearless Girl statue. aerospace stocks"><div>Source: Tun Pichitanon / Shutterstock.com</div></div><p><strong>Virgin Galactic</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/spce-stock-quote/"><strong>SPCE</strong></a>) is an aerospace company that aims to make commercial spaceflight a reality. However, I believe their lofty ambitions may be nothing more than a pipe dream at this point. The stock has been absolutely crushed over the past few quarters as the company hemorrhages cash at an alarming rate. It has been forced to heavily dilute shareholders just to keep the lights on.</p>



<div><a href="https://investorplace.com/wp-content/uploads/2024/06/chart-57.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/06/chart-57.png" alt="Virgin Galactic financials"><br>Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><p>While the idea of space tourism sounds exciting, I&rsquo;m skeptical there&rsquo;s a large enough market of wealthy individuals willing to shell out hundreds of thousands of dollars for a brief joyride to the edge of space in 2024. Virgin Galactic seems to be far ahead of its time, with many high-net-worth individuals not even aware the company exists.</p>



<p>The recent <a href="https://www.marketwatch.com/story/virgin-galactic-shares-plunge-on-reverse-stock-split-announcement-5275d5a8" target="_blank">reverse stock split announcement</a> only reinforces my bearish stance. I wouldn&rsquo;t be surprised to see Virgin Galactic enter a vicious cycle of endless dilution and reverse splits in the coming years just to avoid being delisted. As such, I think it is one of the top stocks to sell.</p>



<p><em>On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/money-pit-warning-7-stocks-to-sell-asap-before-they-die/">Money Pit Warning: 7 Stocks to Sell ASAP Before They Die</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Money Pit Warning: 7 Stocks to Sell ASAP Before They Die

Notable earnings before Wednesday's open

Healthcare Services Q2 2024 Earnings Preview

Healthcare Services Non-GAAP EPS of $0.20 in-line, revenue of $426.28M beats by $1.38M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Healthcare Services Group</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/hcsg-stock-quote/"><strong>HCSG</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Healthcare Services Group reported earnings per share of 20 cents. This met the analyst estimate for EPS of 20 cents.</li><li>The company reported revenue of $426.29 million.</li><li>This was 0.33% better than the analyst estimate for revenue of $424.90 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/07/hcsg-stock-earnings-healthcare-services-group-for-q2-of-2024/">HCSG Stock Earnings: Healthcare Services Group Meets EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

HCSG Stock Earnings: Healthcare Services Group Meets EPS, Beats Revenue for Q2 2024

Healthcare Services Group, Inc. (HCSG) Q2 2024 Earnings Call Transcript

In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on Healthcare Services (HCSG – Research Report), with a price t...

RBC Capital Remains a Buy on Healthcare Services (HCSG)

In a report released today, Bill Sutherland from Benchmark Co. maintained a Buy rating on Healthcare Services (HCSG – Research Report), with a pric...

Benchmark Co. Remains a Buy on Healthcare Services (HCSG)

Healthcare Services Group names Vikas Singh as CFO

Healthcare Services ( ($HCSG) ) has shared an announcement. Healthcare Services Group, Inc. has appointed Vikas Singh as the new Executive Vice Pre...

Healthcare Services Announces Key Executive Appointments

ALKS

ALLE

BNPQF

BPOP

BSBR

BXMT

CHKP

CHPT

EQNR

FLEX

IBDSF

NAVI

ODFL

ORAN

OTIS

OTLY

PETS

RBGPF

RIVN

SEDG

SLAB

SPCE

TECK

TMHC

UNCRY

Press Releases

HCSG Reports Q3 2023 Results; Raises Cash Flow Expectations

HCSG Reports Q4 2023 Results

HCSG Reports Q1 2024 Results

HCSG Provides Update On Client Restructuring; Reiterates 2024 Cash Flow Forecast & ROY Outlook

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Healthcare Services Group

Healthcare Services Group (HCSG) Forecast

Healthcare Services Group (NASDAQ:HCSG) Stock, Quote.Headers.trade-ideas